Rezolute

$0.00 (0.00%) Today
+$0.06 (+0.92%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rezolute and other ETFs, options, and stocks.

About RZLT

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema.

CEO
Nevan Charles Elam
Employees
26
Headquarters
Redwood City, California
Founded
2010

RZLT Key Statistics

Market Cap
61.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
20.80K
High Today
$6.54
Low Today
$6.25
Open Price
$6.45
Volume
132.72K
52 Week High
$20.99
52 Week Low
$5.88

RZLT Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure